Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Registry to Evaluate Pregnancy Outcomes in Women Treated With Elagolix

NCT04464187 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04464187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04464187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Registry to Evaluate Pregnancy Outcomes in Women Treated With Elagolix
Lead sponsor
AbbVie
Phase
Observational
Overall status
Terminated
Start date
January 6, 2022
Completion date
July 11, 2025
Enrollment
173 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis, uterine fibrioids